Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Shanghai Boxun Medical Biological Instrument Days Payable?
Shanghai Boxun Medical Biological InstrumentBJSE:920504 69 Days Payable is 135.57 as of Mar. 2026, which is 35% above its 10-year median of 100.16. GuruFocus rates BJSE:920504 with a GF Score™ of 69/100 and a GF Value™ of ¥19.47 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Shanghai Boxun Medical Biological Instrument ranks better than 62.89% on this metric.
BJSE:920504's Days Payable is ranked better than 62.89% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs BJSE:920504: 94.03
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument Days Payable Chart
Shanghai Boxun Medical Biological Instrument Annual Data
BJSE:920504 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Shanghai Boxun Medical Biological Instrument's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Boxun Medical Biological Instrument Days Payable vs Medical Devices & Instruments Industry
Shanghai Boxun Medical Biological Instrument Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Boxun Medical Biological Instrument (BJSE:920504) has a Days Payable of 135.57 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. This is 35% above median its historical median of 100.16. Over the past decade, Shanghai Boxun Medical Biological Instrument's Days Payable has ranged from 90.70 to 113.38. According to the industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #295 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 37.1%.
Is Shanghai Boxun Medical Biological Instrument's Days Payable too high?
Shanghai Boxun Medical Biological Instrument's current Days Payable of 135.57 is 35% above median its 10-year median of 100.16. Over the past 10 years, this metric has ranged from a low of 90.70 to a high of 113.38. The Medical Devices & Instruments industry median Days Payable is 67.87. Shanghai Boxun Medical Biological Instrument's value of 135.57 is 99.7% above this industry median. Based on the distribution chart, Shanghai Boxun Medical Biological Instrument ranks #295 out of 795 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shanghai Boxun Medical Biological Instrument has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Boxun Medical Biological Instrument's Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shanghai Boxun Medical Biological Instrument ranks #295 out of 795 companies for Days Payable. This puts Shanghai Boxun Medical Biological Instrument in the upper half of its industry. The industry median Days Payable is 67.87. Shanghai Boxun Medical Biological Instrument's value of 135.57 is 99.7% above this benchmark. Historically, Shanghai Boxun Medical Biological Instrument's own Days Payable has ranged from 90.70 to 113.38 over the past decade. While the company's 10-year median is 100.16 vs. the industry median of 67.87, Shanghai Boxun Medical Biological Instrument has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Boxun Medical Biological Instrument's current Days Payable of 135.57 is 99.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Boxun Medical Biological Instrument and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Boxun Medical Biological Instrument's current Days Payable is 135.57, which is 35% above median its own 10-year median of 100.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Boxun Medical Biological Instrument stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument (BJSE:920504) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥19.47, compared to a current price of ¥17.11 — trading 12.1% below its estimated fair value. The current Days Payable is 135.57, which is 35% above median its 10-year median of 100.16 and 99.7% above the Medical Devices & Instruments industry median of 67.87. Shanghai Boxun Medical Biological Instrument's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai Boxun Medical Biological Instrument (BJSE:920504), the current Days Payable is 135.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Boxun Medical Biological Instrument (BJSE:920504) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Boxun Medical Biological Instrument stock appears to be undervalued.
The current stock price of ¥17.11 is trading 12.1% below its estimated GF Value™ of ¥19.47.
GuruFocus considers Shanghai Boxun Medical Biological Instrument to be Modestly Undervalued.
Key valuation signals for BJSE:920504:
Days Payable: 135.57 (35% above median its 10-year median of 100.16)
GF Value™: ¥19.47 vs. price of ¥17.11 (12.1% below fair value)
Industry Position: 99.7% above the Medical Devices & Instruments median (#295 of 795)
No single metric tells the full story. See the BJSE:920504 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Boxun Medical Biological Instrument Corp is engaged in Research and development, production, sales, and service of laboratory equipment and life science instruments. The company's main products are temperature and humidity control series products, high-pressure sterilization series products, and purification safety series products, etc.
69GF Score
Get the complete analysis for BJSE:920504
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920504 has been successfully added to your 
